been some major updates to their prospects.   

 

Timeline is now approx 7 months before an expected FDA decision.

 

Share price is at $5 and change

 

JPMorgan just came out and upgraded the target price to $19 which is $5/sh higher than mine.  But mine is also conservative cause there are some unknowns with regard to sales and revenues and reimbursements and...

 

  and there is a post on the CRMD board by someone named EASYRIDER..    close to 50 recs, and the recs are well deserved for what he sums up..   and I agree with all of it.

 

  Anyways, maybe CRMD finally gets to move forward.   And if we are correct, $14/19 will be the first step..